Miplyffa

Active Ingredient(s): Arimoclomol Citrate
FDA Approved: * September 20, 2024
Pharm Company: * ZEVRA DENMARK AS
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Miplyffa 124 mg Oral Capsule
NDC: 72542-124
Labeler:
Acer Therapeutics Inc.
Miplyffa 47 mg Oral Capsule
NDC: 72542-147
Labeler:
Acer Therapeutics Inc.
Miplyffa 62 mg Oral Capsule
NDC: 72542-162
Labeler:
Acer Therapeutics Inc.
Miplyffa 93 mg Oral Capsule
NDC: 72542-193
Labeler:
Acer Therapeutics Inc.